New therapeutic approach stops glioblastoma from hijacking the immune system

A study appearing in Nature investigated the role of astrocytes, an abundant cell type in the brain, in regulating an immune response against glioblastoma (GBM)—a highly aggressive brain cancer. Researchers found a subset of astrocytes that limits the immune response and can be targeted with therapeutics.

Leave A Comment

Your email address will not be published. Required fields are marked *